SEC Filings

SEC Filings
Home / SEC Filings

SEC Filings

Form DEF 14A
PROTALIX BIOTHERAPEUTICS, INC. filed this Form DEF 14A on 03/16/2017
Document Outline
Entire Document (1881.8 KB)
Subdocument 1 - DEF 14A - DEF 14A
Page 1 - (Name of Registrant as Specified In Its Charter)
Page 2 - Web: www.protalix.com
Page 3 - Please sign, date and promptly return the enclosed proxy card in the enclosed envelope, or vote by t
Page 4 - You can also find a copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 20
Page 5 - N/A
Page 6 - N/A
Page 7 - Approval, in accordance with Section 713(a) of the NYSE MKT Company Guide, of the potential issuance
Page 8 - Please complete your proxy and return it as instructed so your vote can be counted.
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - Shlomo Yanai.
Page 14 - Moshe Manor.
Page 15 - Aharon Schwartz, Ph.D.
Page 16 - N/A
Page 17 - http://www.protalix.com
Page 18 - N/A
Page 19 - N/A
Page 20 - Moshe Manor.
Page 21 - Tzvi Palash.
Page 22 - Annual Bonus.
Page 23 - Severance and Change in Control Benefits.
Page 24 - N/A
Page 25 - N/A
Page 26 - Moshe Manor.
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - The information contained in this report shall not be deemed to be soliciting material or to be file
Page 31 - Our Board of Directors recommends that stockholders vote FOR the approval of the executive compensat
Page 32 - N/A
Page 33 - N/A
Page 34 - Our Board of Directors recommends that stockholders vote FOR to approve, in accordance with Section
Page 35 - N/A
Page 36 - Our Board of Directors recommends that stockholders vote FOR the approval of the Amendment to the Ce
Page 37 - Our Board of Directors recommends that stockholders vote FOR the ratification of the appointment of
Page 38 - http://www.sec.gov
Page 39 - N/A
Page 40 - N/A
Page 41 - N/A
Page 42 - N/A
Page 43 - N/A